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A B S T R A C T
Insuﬃcient suppression and connectivity of the default mode network (DMN) is a potential mediator of cognitive
dysfunctions across various disorders, including attention deﬁcit/hyperactivity disorder (ADHD). However, it
remains unclear if alterations in sustained DMN suppression, variability and connectivity during prolonged
cognitive engagement are implicated in adult ADHD pathophysiology, and to which degree methylphenidate
(MPH) remediates any DMN abnormalities. This randomized, double-blinded, placebo-controlled, cross-over
clinical trial of MPH (clinicaltrials.gov/ct2/show/NCT01831622) explored large-scale brain network dynamics
in 20 adults with ADHD on and oﬀ MPH, compared to 27 healthy controls, while performing a reward based
decision-making task. DMN task-related activation, variability, and connectivity were estimated and compared
between groups and conditions using independent component analysis, dual regression, and Bayesian linear
mixed models. The results show that the DMN exhibited more variable activation patterns in unmedicated
patients compared to healthy controls. Group diﬀerences in functional connectivity both between and within
functional networks were evident. Further, functional connectivity between and within attention and DMN
networks was sensitive both to task performance and case-control status. MPH altered within-network con-
nectivity of the DMN and visual networks, but not between-network connectivity or temporal variability. This
study thus provides novel fMRI evidence of reduced sustained DMN suppression in adults with ADHD during
value-based decision-making, a pattern that was not alleviated by MPH. We infer from multiple analytical ap-
proaches further support to the default mode interference hypothesis, in that higher DMN activation variability
is evident in adult ADHD and associated with lower task performance.
1. Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) is characterised by
age-inappropriate inattention and/or impulsivity/hyperactivity
(American Psychiatric Association, 2013). Individuals with ADHD dis-
play deﬁcits in higher order decision-making processes (Sagvolden
et al., 2005; Sonuga-Barke et al., 2016). In childhood and adolescence,
psycho-stimulant medication eﬀectively reduces ADHD symptoms
(Fredriksen and Peleikis, 2015) and ameliorate abnormal functioning in
dopamine (DA) dense fronto-striatal and mesolimbic brain networks in
ADHD due to the inhibition of synaptic reuptake of DA in these
networks (Arnsten, 2006; Volkow et al., 2009, 2005) – eﬀects that are
reﬂected in improved functioning in executive functions and reward
processing in ADHD (Barkley et al., 2001; Mowinckel et al., 2015).
ADHD persists into adulthood for many patients (Biederman et al.,
2011), but it is currently unclear whether normalization of brain
function from stimulant medication is equivalent in adults and children
with the condition (Bush et al., 2008; Epstein et al., 2007; Schrantee
et al., 2016).
Brain-behaviour relations are built on the interaction between
multiple intrinsic functional neural networks comprised of spatially
distributed regions through temporally correlated activity (Beckmann
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and Smith, 2004; Smith et al., 2009). Disruptions within or between
such networks may result in behavioural abnormalities (Sonuga-Barke
and Castellanos, 2007; Sripada et al., 2014). These intrinsic functional
networks are most commonly studied during rest, but show coherence
during both rest and task engagement (Smith et al., 2009). One ap-
proach to elucidating the involvement of functional brain networks on
cognitive operations is to study how strongly speciﬁc networks are
engaged during cognitive tasks, for instance, by analysing the correla-
tion between network time series and known task parameters. Another
way of assessing the relevance of functional networks is by studying
temporal BOLD signal variance. It is presumed that signal variance
reﬂects the dynamic allocation of resources to brain regions utilized
during cognitive operations, such that greater variability is indicative of
greater ﬂexibility or adaptability of those regions (Faisal et al., 2008;
Grady and Garrett, 2014).
It has been proposed that DA modulates signal integrity in the brain
(Garrett et al., 2015). A recent study found that younger, higher per-
forming adults had greater blood-oxygen level dependent (BOLD) signal
variability in task-relevant cortical regions than older (likely DA de-
pressed) adults during a working-memory task (Garrett et al., 2015).
Interestingly, d-amphetamine (which increases DA availability) in-
creased signal variability in the older participants, which also improved
task performance. This raises the question whether abnormal signal
variability may be found in psychopathologies with known DA deﬁcits,
such as ADHD, and whether a DA agonist will increase BOLD variability
in task-positive networks and task performance.
Disrupted interplay within and between “task-positive” (i.e. net-
works essential for task execution) and “task-negative” functional net-
works (i.e. networks supporting oﬀ-task processing) is implicated in
ADHD where it manifests as inattention and impulsivity (Castellanos
and Proal, 2012; Sonuga-Barke and Castellanos, 2007). In particular,
the task-negative default mode network (DMN), which includes the
posterior cingulate cortex, precuneus, and medial frontal cortex, has
been hypothesized to play a pivotal role. The DMN is mostly active
during rest, attenuated during externally oriented cognition, and is
thought to be involved in self-referential or internally oriented pro-
cesses (Andrews-Hanna et al., 2010). Speciﬁcally, the default mode in-
terference hypothesis proposes that inattentiveness in ADHD may be
caused by insuﬃcient down-regulation of the DMN during goal-or-
iented processes (Castellanos and Proal, 2012; Sonuga-Barke and
Castellanos, 2007). Reduced suppression of the DMN may disrupt task-
positive networks and lead to lapses of attention and excessive “mind-
wandering”. Weissman et al. (2006), for instance, showed that reduced
deactivation of the precuneus (posterior DMN) preceded attentional
lapses during a goal-oriented task. Indeed, patients with ADHD have
documented weakened within-network connectivity in the DMN and
several task-positive networks (Kessler, Angstadt, Welsh, Sripada, and
Kessler, 2014; Uddin, Kelly, Biswal, Castellanos, and Milham, 2009), as
well as increased functional and structural connectivity between the
DMN and task-positive networks during rest (Kessler et al., 2014).
The pattern of decreased within network connectivity and increased
between network connectivity has furthermore lead to the proposal that
functional networks are less clearly segregated in ADHD (Hoekzema
et al., 2013; Kessler et al., 2014). Functional connectivity networks are
more strongly diﬀerentiated in adults than children (Fair et al., 2008;
Rubia, 2013), and it has been suggested that reduced diﬀerentiation of
functional networks in patients with ADHD is caused by a brain ma-
turation lag (Fair et al., 2010; Sripada et al., 2014). Reports of more
diﬀuse functional networks also in adults with ADHD suggest that
network diﬀerentiation reaches an earlier plateau than in healthy
controls (Hoekzema et al., 2013), and the disruptions in functional
connectivity thus become more established features of the mature
ADHD brain.
Functional connectivity is suggested to be improved by increased
DA availability (Nagano-Saito et al., 2008). Liddle et al. (2011) found
that DMN suppression during task was improved by MPH, and others
have found that MPH increases DMN suppression as a function of task
diﬃculty (Metin et al., 2015). Hence, the therapeutic eﬀect of MPH, a
DA reuptake inhibitor frequently prescribed for treating ADHD symp-
toms, may partly be mediated through its eﬀects on large-scale brain
connectivity. Importantly, while MPH is often only discussed in the
context of DA, it also has an agonistic eﬀect on the noradrenaline (NA)
system (Ziegler et al., 2016). There are therefore two routes by which
increased striatal DA can inﬂuence cortical functioning, despite low
expression of the DAT in the cortex. First, manipulation of cortical
activity through striatal DA via the cortico-striatal loop neurons (e.g.
Grace et al., 2007; Krugel et al., 2009). And secondly, due to the rela-
tively stronger expression of the NA transporter (Schroeter et al., 2000),
via heightened NA availability in the cortex.
More generally, Sidlauskaite et al. (2016) question whether docu-
mented abnormalities in DMN suppression in ADHD are in fact re-
ﬂecting diﬃculties in sustaining DMN suppression, as their study shows
that initial DMN suppression when cued to execute a task is not im-
paired in ADHD. However, this hypothesized dysfunction in sustaining
DMN suppression has yet to be explored in ADHD. Moreover, a study of
network connectivity found that MPH reduced the connectivity be-
tween the DMN and attention networks during rest in healthy adults
(Sripada et al., 2013). Only one study, however, has explored disrup-
tions both within and between functional networks in adults with
ADHD (Kessler et al., 2014), and the possible amelioration of such
disruptions by MPH remains unexplored.
Taken together research suggests that patients with ADHD struggle
to engage with tasks due to weak down-regulation of the DMN during
task transitions, and that MPH increases the ability to suppress the DMN
and also reduces its temporal coherence with task-positive networks. In
this double-blinded, placebo-controlled, crossover trial of MPH on
adults with ADHD, we aimed to characterise functional brain-network
abnormalities during decision-making in adult patients with ADHD and
the possible ameliorating eﬀects of MPH. To this end, based on event-
related fMRI data obtained from 20 patients and 27 controls, where the
patients were randomly assigned to MPH (short: medicated patients) or
placebo (short: unmedicated patients) in a repeated-measures cross-
over design. We used group independent component analysis (ICA)
(Beckmann and Smith, 2004) to deﬁne the group level brain network
nodes and dual regression (Filippini et al., 2009) to estimate the in-
dividual spatial maps and associated time series. A multiple analysis
approach was adopted to illuminate the subject from diﬀerent angles,
where we assessed the intrinsic networks' engagement by known task
variables, the temporal variance of the networks, and both the within
and between network connectivity of the networks. We expected typical
task-positive networks to have BOLD time series that correlate with
decision phases of the task GLM, indicating that these networks are
involved in task execution. Further, we anticipated reduced task related
engagement of functional networks in adults with ADHD compared to
controls during task transitions, and that MPH would improve task
related modulations of networks. We additionally anticipated that
temporal variability in task-positive networks would be reduced in the
patient group compared to controls. Given the documented abnormal-
ities in DMN activation during task in ADHD, we also predicted in-
creased temporal DMN variability in the patient group, indicating that
the DMN is overactive when it should be suppressed. Because of pre-
vious reports of DA agonists increasing BOLD variability, we also pre-
dicted that MPH would increase temporal variability in task-positive
networks. In order to support previous reports of less segregated
functional networks in ADHD, we lastly investigate within-network
connectivity in the posterior DMN (precuneus) and between-network
connectivity between the DMN and task positive networks in ADHD
unmedicated patients, and also expected an amelioration of any con-
nectivity abnormalities as a result of MPH.
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2. Methods and materials
This is a secondary investigation of a randomized double-blinded
placebo-controlled clinical trial of methylphenidate on adults with
ADHD (clinicaltrials.gov/ct2/show/NCT01831622), and we only
brieﬂy describe the study protocol here. Participants were tested at the
Intervention Centre at Oslo University Hospital, Rikshospitalet. The
entire testing procedure lasted 2–3 h, including two 30-min sessions in
the scanner. The study was approved by the Regional Committee of
Medical Health Research Ethics (South-East Norway; identiﬁers: 2011/
1585 and 2012/1105), and the Norwegian Medicines Agency (EudraCT:
2012-005246-38). Informed consent was obtained from all participants,
and the research was carried out in compliance with the Helsinki
Declaration.
2.1. Participants
All participants had to be between 18 and 40 years old and have
normal or corrected to normal vision (full list of exclusion criteria in
Supplemental materials S1.1). ADHD patients were recruited through
an outpatient clinic at Vestfold Hospital Trust, Norway, and were di-
agnosed and currently receiving care at the same clinic. The ADHD
diagnosis was ascertained by a multistage and multisource procedure
according to DSM-IV-TR criteria (American Psychiatric Association,
1994), described in detail in Supplemental materials S1.2. Patient
participants could not currently be receiving pharmacological treat-
ment for other psychiatric disorders.
The controls were recruited through a random selection of 3.000
men and women through the Norwegian Tax Agency (Skatteetaten),
and received an invitation via mail to participate in the research pro-
ject. Among the 372 persons who responded to the query, only parti-
cipants matching patient participants on age and sex were contacted.
The responding prospective controls had generally high levels of edu-
cation, and matching for this proved diﬃcult. Control participants were
screened with the Adult ADHD self-report scale (Kessler et al., 2007) via
telephone, and were excluded if they scored 15 or higher on the ﬁrst 6
items (Hines et al., 2012). Thirty-three control participants were in-
cluded.
Twenty-eight clinically diagnosed adults with ADHD (19 female/9
male) and 33 healthy age-matched controls (21f/12m) performed a
reward-based decision-making task during functional MRI acquisition.
Participants were well-matched on age before exclusions (mean [SD]
age ADHD= 27.5 [1.17], controls = 27.3 [1.03]). Fourteen partici-
pants were excluded for either technical issues with their data (2
ADHD, 1 control), were lost to follow-up (1 ADHD, 1 control), re-
sponding to too few trials (3 ADHD, 1 control) or having performance at
chance levels (< 60% accuracy; 2 ADHD, 1 control). A total of 20
patients (13f/7m) and 27 controls (19f/8m) were included in the ﬁnal
analyses. All viable datasets were included to maintain statistical
power. While there was a robust diﬀerence in age after exclusion (pa-
tients being meanly 2.5 (SD 1.9) year younger than controls), the
practical diﬀerence between a 27 and 29-year-old, ages where there are
few expected cognitive diﬀerences related to age, should be negligible.
All control participants were right-handed (missing data from one
participant), and in the patient group there were 4 left, 15 right, and 1
ambidextrous participants. All male patients were diagnosed as pre-
dominantly inattentive subtype, while the female patients were both
inattentive (8) and of combined type (5). Summaries of group demo-
graphic variables and task performance are summarized in Table 1.
2.2. Experimental procedures
In a double-blinded crossover procedure, ADHD patients were ad-
ministered MPH one session and placebo the other in randomized
order. All patients were thus tested both on and oﬀ MPH.
Randomization was un-blinded after the last participant completed the
study, assuring that both study personnel and participants remained
blind to the pharmacological intervention. Details on the blinding
procedures are in Supplemental materials S1.3. The number of patients
allocated to the diﬀerent doses (close to their prescribed doses) was: 6
to instant-release tablets (IR-T) 10 mg, 3 to IR-T 20 mg, 7 to slow-re-
lease capsules (SR-C) 20 mg, and 4 to SR-C 40 mg.
Blood samples from volunteering patient participants were collected
between two MRI acquisition sequences to conﬁrm patients were un-
medicated in the placebo condition and quantify the amount of ritalinic
acid (metabolite of methylphenidate) in their blood serum during
testing (details on the acquisition and results from the blood analyses
can be found in Supplemental materials S1.4). Blood samples were
batch analysed after data collection was completed.
2.3. Behavioural task
The value-based decision-making task used in this study was ﬁrst
introduced by Basten et al. (2010) and is comprised of two stages.
Outside the scanner, participants ﬁrst learn to associate 6 positive and 6
negative monetary value ranges to stimuli through trial and error. The
participants train on the stimulus association until a criterion of 95%
correct is achieved, with a minimum number of 180 trials and maxi-
mally for 270 trials. In the fMRI experiment, participants are presented
with one composite ﬁgure consisting of both an associated positive and
negative value range, and are asked to accept stimuli with summed
positive values and reject the negative. Participants could win up to
250 NOK (~30 USD) based on their performance. The participants
viewed the stimuli on a screen through mirrors, and responses were
recorded using a response box with the index and middle ﬁngers of the
participants' dominant hand. Participants completed 88 trials in two
runs, 176 trials per session. Stimuli were presented for maximally 2.5 s




Scanning was conducted on a 3 Tesla Philips Achieva whole-body
scanner, with an 8 channel Philips SENSE head coil (Philips Medical
Systems). Two sets of functional data were collected with the following
sequencing parameters: 333 volumes, 3 × 3 × 3 mm, TE = 30 ms,
TR = 2.3 s, resulting in 12 min of event-related functional scans.
Anatomical images were acquired with a T1 weighted scan with voxel
size of 1 × 1 × 1 mm; 180 sagittal slices; TR: 6.6 ms. Participants were
given coil padding to reduce head movement.
2.4.2. Image processing
Removal of skull and non-brain tissue of the anatomical images was
conducted with Freesurfer (Ségonne et al., 2004), and functional
images were pre-processed with FMRIB's FSL (Jenkinson et al., 2012).
Pre-processing included MCFLIRT motion correction, non-linear regis-
tration to MNI space, high-pass ﬁltering (100 s), slice-timing correction,
brain extraction, spatial smoothing (FWHM= 6 mm), intensity nor-
malization, and single-session independent component analysis (ICA)
using MELODIC (Beckmann and Smith, 2004). ICA-based Xnoiseﬁer FIX
(Salimi-Khorshidi et al., 2014) was used to identify and remove noise
components on an individual level using a machine learning approach
after initial pre-processing (with a custom training data set for Philips
scanner, threshold: 20; p(component = signal) < 20%). This method
has been shown to eﬀectively reduce the impact of head motion, while
retaining temporal degrees-of-freedom and increasing reproducibility
of independent components (Pruim et al., 2015).
2.4.3. Analysis
A group-PCA approach (Smith et al., 2014) was conducted using
MELODIC including all scans requesting 40 components. A model order
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of 40 should provide suﬃciently low number of components for easy
interpretation, while still maintaining adequate spatial segmentation.
Following this, the individual time series and component spatial maps
were estimated using dual regression (Filippini et al., 2009). Based on
the recommendation of Kelly et al. (2010), we went through the spatial
distribution of the components and identiﬁed 22 noise components. The
time-series from these 22 components were regressed out of the re-
maining dataset. The remaining 18 clean components and associated
time series constituted the nodes in the subsequent analyses with a total
of 188 datasets (47 participants at two time points with two fMRI se-
quences from each time point). The 18 nodes were classiﬁed into
functional networks according to correspondence with BrainMap 20-
networks identiﬁed in Smith et al. (2009) (see Supplemental table S1.5-
1 for spatial correlations and Supplemental ﬁg. S1.5-1 for all 40 com-
ponents). We additionally identiﬁed a node in the orbitofrontal cortex
(OFC; IC 27), a region known to be involved in decision-making (Hare
et al., 2008), and a subcortical node primarily consisting of the striata
(IC 29), which are important for value-representation during decision-
making (Basten et al., 2010). Both of the additional nodes include re-
gions that have shown impaired function during decision-making in
ADHD (Mowinckel et al., n.d.; Ströhle et al., 2008; Wilbertz et al.,
2012).
The 18 nodes were classiﬁed to known functional networks both by
manual inspection and through voxel-wise spatial correlation to a
previously described independent component atlas (Smith et al., 2009),
and are summarized in Fig. 1. Node 1 was identiﬁed as the main
component of the default mode network, accompanied by node 20
(red). The cerebellum is covered by node 16 (orange), and the auditory
cortices by node 26 (yellow). The visual network is comprised of nodes
4, 8, and 9 (dark green), and the sensorimotor network includes nodes
13 and 17 (light blue). The frontoparietal network is comprised of 6
nodes (purple; 2, 6, 7, 10, 11, and 12), where node 6 likely reﬂects the
dorsal attention network (DAN) and node 7 and 12 likely reﬂect the
right and left ventral attention networks (VAN), respectively. The ex-
ecutive control, or “salience”, network is identiﬁed as node 5 (pink). In
addition to the nodes described by Smith et al. (2009), we identiﬁed a
subcortical node 29 (light green) and an orbitofrontal cortex node 27
(dark blue).
After obtaining subject-speciﬁc time series for the 18 nodes, general
linear models (GLMs) with decision phase, the positive and negative
value of each stimulus (gain and loss), the absolute diﬀerence of the two
latter (diﬃculty), and trial accuracy were convolved with a double-
gamma HRF and used as linear predictors for the subject speciﬁc node
time series. The regressors gain, loss, and diﬃculty were orthogonalized
with respect to decision phase, as advised in Mumford et al. (2015). The
unmodulated decision phase regressor may then be interpreted as the
mean activation across trials. This gave us individual-level beta-weights
for the task-parameters of interest (decision phase, gain, loss, accuracy,
and diﬃculty) for each node. Nodes relevant for task execution are
expected to show task-dependent BOLD-activations, task-negative net-
works like the DMN are expected to show activity reductions in re-
sponse to task events. Nodes showing modulation by choice and
changes due to the drug-manipulation or diﬀerence between groups
were targeted as nodes of interest for subsequent analyses.
Secondly, we ran analyses on the node time series variance and the
pairwise node-to-node regularized partial correlations (between-net-
work connectivity) using FSLNets (v. 06). As node variance, we calcu-
lated the subject speciﬁc time series variance of the 18 nodes. For the
pairwise node correlations, we calculated partial correlations between
the time series of the 18 nodes, which resulted in 153 unique
Table 1
Summary of posterior probabilities of group demographics and task performance. Education is measured as the years to completion of highest achieved degree. Scores from the Wechsler's
Adult Intelligence Scale (WAIS-IV) are age-scaled. Diﬀerence between the groups was tested with Bayesian linear mixed models, and the posterior probabilities are summarized by the
mean, standard deviation, and 95% highest density interval (HDI). The credibility of the diﬀerence distribution is assessed by the proportion of the distribution that is above or below 0
(Prop. > 0 <), which can be seen as the posterior conﬁdence for a directed eﬀect. Diﬀerence distributions where over 90% of posterior distribution of parameter diﬀerences are above or
below zero are highlighted in bold.
Summary of posterior probabilities
Measure Group Mean SD 95% HDI Prop.≥ 0 <
Age (years) ADHD 29.90 1.41 27.21 32.68
Controls 27.42 1.23 25.17 29.98
CON-ADHD −2.48 1.86 −6.09 1.12 0.088
Education (years) ADHD 12.25 0.46 11.41 13.19
Controls 14.55 0.39 13.77 15.29
CON-ADHD 2.30 0.60 1.16 3.51 1.000
Visit interval (days) ADHD 32.14 2.02 28.35 36.32
Controls 27.08 1.84 23.50 30.65
CON-ADHD −5.06 2.73 −10.61 0.41 0.036
WAIS Matrices ADHD 12.46 0.71 11.08 13.82
Controls 12.44 0.61 11.25 13.60
CON-ADHD −0.01 0.93 −1.84 1.76 0.498
WAIS Similarities ADHD 10.87 0.78 9.43 12.52
Controls 13.03 0.65 11.81 14.36
CON-ADHD 2.16 1.04 0.11 4.20 0.982
Accuracy (log odds) Eﬀect of ADHD 0.54 0.20 0.14 0.93 0.995
Eﬀect of MPH 0.17 0.13 −0.08 0.42 0.910
Placebo 1.87 0.16 1.55 2.20
Controls 2.33 0.66 1.04 3.64
MPH 2.04 0.17 1.69 2.37
Response time (ms) Eﬀect of ADHD 56.57 59.56 −61.11 175.90 0.831
Eﬀect of MPH −8.29 37.36 −79.50 65.89 0.410
Placebo 1026.80 51.83 927.56 1132.53
Controls 920.52 197.76 541.24 1315.31
MPH 1018.52 51.25 917.17 1116.42
RT variability (coeﬃcient) Eﬀect of ADHD 0.02 0.02 −0.02 0.05 0.862
Eﬀect of MPH 0.00 0.02 −0.03 0.03 0.449
Placebo 0.33 0.02 0.30 0.36
Controls 0.37 0.06 0.26 0.49
MPH 0.33 0.02 0.30 0.36
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combinations that we here call edges. Each edge is thus the partial
correlation between two of the 18 nodes, and were estimated using L1-
regularized partial correlations in FSLNets, with automatic strength
regularization of lambda on the individual subject level (Kaufmann
et al., 2016; Ledoit and Wolf, 2003).
For assessment of within-network connectivity, cross-subject whole-
brain voxel-wise permutation tests were run on nodes correlated with
task parameters using FSL's non-parametric tool randomize (Winkler
et al., 2014). GLMs were run with 5000 permutations, voxel-wise cor-
rection for multiple comparisons with threshold-free cluster enhance-
ment (TFCE) (Salimi-Khorshidi et al., 2011) and Bonferroni correction
per node tested at p < 0.05. The subject speciﬁc whole-brain maps
were submitted to randomize with GLMs specifying participant condi-
tion (MPH, placebo, control), with contrasts comparing each group to
each other in a repeated design (control vs. placebo, control vs. MPH,
placebo vs. MPH) with block-wise permutations. This provides metrics
on within-node connectivity in each node that is reliably diﬀerent be-
tween groups or due to the drug-manipulation.
2.5. Statistical analysis
R statistical software (v. 3.2.5) (RCore Team. R., 2013) with
packages for Bayesian hierarchical mixed model analyses (Rstan [v.
2.9.0-3], Rstanarm [v. 2.9.0-4]) (Carpenter et al., 2017; Stan
Development Team, 2016) was used for inference testing on the edges,
node variance, and task parameter betas. Bayesian hierarchical re-
gressions were run with behavioural measures from the task (accuracy,
response time, and response time variability [standard deviation of
response time divided by mean response time]), task betas, node var-
iance, and edge correlations as dependent variables. To shrink top-level
regression weights towards zero, Rstanarm's default weakly informative
priors were used for analyses. By using multilevel Bayesian models, the
point estimates are shifted towards each other and towards the main
eﬀect(s), resulting in posterior densities that are appropriately con-
servative without sacriﬁcing power (Gelman et al., 2012), which ne-
gates the need for multiple comparison corrections (Gelman and
Tuerlinckx, 2000).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2017.03.008.
All models were run with four Hamiltonian Monte Carlo chains of
10,000 iterations each, whereby the ﬁrst 5000 samples of each chain
were discarded before further analysis (i.e. warm-up). Hence, all re-
ported results were based on 20,000 posterior samples (5000 per
chain). We assessed convergence of all models by assuring that all Rhat
values were below 1.1, and that the minimum number of eﬀective
samples were above 300 (Gelman and Rubin, 1992). To control the
number of divergent iterations, the target acceptance rate (adapt_delta)
of Stan's Hamiltonian Monte Carlo algorithm was set to 0.99 (Stan
Development Team, 2015) (see Supplemental ﬁgs. S1.6.1–3 for MCMC
diagnostic plots for the three main analyses). For the Bayesian analysis,
we report the mean, standard deviation, and the 95% highest density
interval of the posterior distributions of the parameters of interest, as
well as the posterior probability that the eﬀect is larger than zero. If the
mean of the posterior probability distribution is smaller than zero, the
diﬀerence is at the opposite tail end of the distribution and we provide
the posterior probability that the eﬀect is smaller than zero, for ease of
interpretation. The amount of the posterior distribution that is above or
below 0 provides a measure of conﬁdence that there is a directed eﬀect,
such that the closer the proportions are to 1 the more reliable the eﬀect
is.
The three competing models were ﬁtted with a step-wise increase of
model complexity, and compared with leave-one-out (LOO) cross-vali-
dation with Pareto-smoothed importance sampling (Vehtari et al.,
2015). Best ﬁtting models were determined by having the highest ex-
pected log point-wise predictive density (ELPD), and if several models
were of equal ﬁt, the model with the lowest complexity was deemed
best ﬁtting. Of the three linear mixed models we ﬁt (modelling parti-
cipants as belonging to one, two, or three groups), model 3 (which
included all three conditions: control, placebo, and methylphenidate)
had the highest LOO-estimates, and all reported values are from this
model (see Supplemental tables S1.7.1–2 for summary of the expected
predictive accuracy of all the models). We measure the eﬀect of having
Fig. 1. Network overview. The 18 nodes identiﬁed from the independent component
analysis, classiﬁed into networks by referencing the Smith et al. (2009) published ICA
atlas. Purple = frontoparietal network; Dark blue = orbitofrontal cortex (OFC); Light
blue = sensorimotor; Orange = cerebellum; Red = default mode network (DMN); Dark
green = visual network; Yellow = auditory network; Light green = subcortical network;
Pink = executive control network (Exec.Contr.). (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the online version of this chapter.)
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ADHD by comparing healthy controls to the patients when in the pla-
cebo condition, and the eﬀect of methylphenidate by comparing pa-
tients on and oﬀ methylphenidate.
2.5.1. Possible confounding subject motion
The functional data was pre-processed in several steps to reduce the
inﬂuence of noise on the results (i.e. motion correction and FIX). To
assess possible retaining eﬀects of subject motion on the subsequent
analyses, we tested volume-wise relative motion with Bayesian linear
mixed models across the three conditions with a varying term allowing
for subject speciﬁc intercept. As these data were less complex than the
main models described above and the purpose was to do data checks,
the model was run with 2000 samples of which half were warm-up. This
model was also run on subject speciﬁc numbers of estimated in-
dependent components (ICs), proportion of classiﬁed noise ICs, and
relative and absolute variance removed by the FIX noise reduction.
Subject speciﬁc mean relative motion was also added as a confounder in
the mixed models of node variance, edge connectivity and task
Fig. 2. Node change by decision-making task parameters. Eleven nodes showed credible diﬀerence between groups in relation to decision phase and/or trial accuracy. Triangles are the
estimated mean distributions for the groups, circles are the calculated diﬀerence distributions between groups (eﬀect of ADHD: controls-placebo; eﬀect of MPH: methylphenidate-
placebo). The error bars denote the 95% highest density interval of the distributions. Solid horizontal lines are the value limits of the plots. Particularly DMN node 1 showed interesting
negative co-variation with both decision phase and accuracy, which was stronger in the patient placebo condition compared to controls in the decision-phase. The node with the strongest
positive association with choice onset was frontoparietal node 6 (DAN), where controls show increased activity compared to patients. This node encompasses the intraparietal sulcus, an
area implicated in evidence accumulation in value-based decision-making (Basten et al., 2010). Activation in node 5 (executive control) showed a strong negative association with trial
accuracy, which was more pronounced in controls compared to patients. Cereb. = cerebellum; DMN= default mode network; Exec.Contr. = executive control network; Frontopar-
i. = frontoparietal network; Subcort. = subcortical network.
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modulation and compared to models without the confound to assess the
importance of motion on the model-ﬁt. However, while several extra
steps were employed to minimize the eﬀects of head motion on statis-
tical inference, we cannot completely rule out that some residual head
motion may still inﬂuence the results.
3. Results
3.1. Task performance
Table 1 summarizes the results from the Bayesian hierarchical linear
mixed model regressions on task performance that revealed that un-
medicated patients had lower accuracy than controls, and that they
made fewer errors in the MPH condition compared to placebo. Un-
medicated patients had slower responses than controls, and this was not
changed by MPH. There were no credible diﬀerences between controls
and unmediated patients or between drug conditions in response time
variability (standard deviation of RT divided by mean RT).
3.2. In-scanner subject motion
Results from the motion analyses indicated that when on methyl-
phenidate, the patients moved less in the scanner than on placebo. Also,
the patients when on methylphenidate had fewer individual level IC's
estimated and less absolute variance removed by FIX than when they
were unmedicated. There was no diﬀerence between patients on pla-
cebo and controls (Supplemental ﬁg. S1.8.1). In light of these results,
we added mean relative motion as a linear predictor to the linear mixed
models of node variance, edge correlations and task related node acti-
vations. These models were compared to the models without the motion
predictor with LOO to assess which models were a better ﬁt to the data.
Of the linear mixed models for the node variance, the model that in-
cluded mean relative motion had greater ELPD estimates and was thus
the best ﬁtting model to the data. No other models were improved by
adding mean relative motion.
3.3. Task related node activation
To assess node modulation by the decision-making task, node time
series were tested with GLMs with task parameters, such as gain and
loss value of the stimuli. All nodes but one (frontoparietal node 7)
showed either positive (nodes 4–6, 8–9, 16–17, 20) or negative (nodes
1–2, 10–13, 26–27, 29) activity changes by the decision phase, 15 with
trial-by-trial accuracy (positive: 2, 4, 9, 11–13, 16–17, 20, 26, 29; ne-
gative: 1, 5, 7, 10), and 6 nodes with diﬃculty (positive: 2, 4–5, 8–10).
No nodes were associated with stimulus gain or loss value (see
Supplemental table S1.9.1 for summary of the posterior probabilities
with credible diﬀerences between groups, and Supplemental table S2.1
for all results from the task GLM). There were seven nodes where the
decision phase modulation additionally showed credible diﬀerences
between controls and patients on and oﬀ medication (Fig. 2), and seven
nodes where the change by trial accuracy was credibly diﬀerent be-
tween controls and patients. None of the task modulations were altered
by methylphenidate.
3.3.1. Decision phase
Comparing the controls to unmedicated patients, the cerebellum
(node 16) was less activated by the decision phase in the patients oﬀ
medication (diﬀerence distribution summary; mean: −0.96; 95%
highest density interval: −1.69 to−0.24; proportion of the diﬀerence
distribution that is above/below zero: 1.00), and so was the DAN (node
6) (M:−0.90; HDI: −1.73 to −0.07; prop. < 0: 0.98), and the three
visual nodes (node 4 [M: −1.44; HDI: −2.20 to −0.68; prop. < 0:
1.0], node 8 [M:−1.49; HDI:−2.3 to−0.77; prop. < 0: 1.0], node 9
[M: −1.82; HDI: −2.60 to −1.06; prop. < 0: 1.0]). The patients oﬀ
medication had weaker negative modulation of frontoparietal nodes 10
(M: 0.71; HDI: −0.01–1.47; prop. > 0: 0.97), 2 (M: 1.05; HDI:
0.32–1.79; prop. > 0: 1.00), and 12 (left VAN) (M: 1.12; HDI:
0.36–1.87; prop. > 0: 1.0) compared to controls. Unmedicated pa-
tients showed stronger negative modulation of DMN node 1 by the
decision phase compared to controls (M: −0.69; HDI: −1.45–0.08;
prop. < 0: 0.96).
3.3.2. Trial-by-trial accuracy
In trials where participants answered correctly, unmedicated pa-
tients had weaker negative activation change of the executive control
network than controls (node 5, M: 2.11; HDI: 1.32–2.89; prop. > 0:
1.0), and weaker positive activation change of the left VAN (node 12,
M: −0.69; HDI: −1.40–0.05; prop. < 0: 0.97). Patients oﬀ medica-
tion weakly activated the DAN (node 6) in correctly answered trials
while controls disengaged it (M: 2.10; HDI: 1.31–2.92; prop. > 0: 1.0).
Controls did not show any activity change relating to trial accuracy,
whereas unmedicated patients positively activated the OFC (M: 0.67;
HDI: −0.04–1.44; prop. > 0: 0.97) and frontoparietal node 2 (M:
1.18; HDI: 0.43–1.91; prop. > 0: 1.0) on correct trials. The opposite
was true for visual node 8, which showed deactivation on correct trials
in controls but not in patients oﬀ medication (M: 1.45; HDI: 0.71–2.23;
prop. > 0: 1.0).
3.4. Node temporal variance
Of the linear mixed models of component variance, model 3 with
mean relative motion as an additional ﬁxed factor, was the best ﬁtting
model for the data (model comparisons including mean relative motion
are in Supplemental materials S1.7.1). As can be seen in Fig. 3A, in the
main DMN component (node 1) patients had higher DMN variance than
controls (M: 0.02; HDI: −0.01–0.05; prop. > 0: 0.90). MPH reduced
node variance in the two sensorimotor nodes (node 13 [M:−0.03; HDI:
−0.07–0.0; prop. < 0: 0.99], node 17 [M: −0.02; HDI: −0.05–0.01;
prop. < 0: 0.92]), and the OFC (node 27 [M: −0.02; HDI:
−0.05–0.01; prop. < 0: 0.99]). MPH increased the variance of fron-
toparietal node 2 (M: 0.02; HDI: −0.01–0.05; prop. > 0: 0.90).
Summary of estimates of node variance are in Supplemental table S2.2.
The DMN (node 1) was the only node whose variance was related to
overall task accuracy, where participants with low DMN variance also
had high overall task accuracy (M: −0.51; HDI: −0.85 to −0.77;
prop. < 0: 1.0; Fig. 3B), an eﬀect which was not reliably diﬀerent
between the groups. Summary of node variance models for group dif-
ferences and task accuracy are shown in Supplemental ﬁg. S1.10.1 and
Supplemental table S2.3.
3.5. Between node connectivity (edges)
As can be seen in Fig. 4, the positive coupling between the left VAN
(node 12) and DMN node 1 (M: 0.02; HDI: −0.00–0.05; prop. > 0:
0.97) and 20 (M: 0.03; HDI: −0.06 to −0.01; prop. > 0: 0.99) was
stronger for the patients than the controls. Otherwise, there was a
general decrease of connectivity when comparing unmedicated patients
with controls between several nodes, including between two visual
nodes (4 and 9), two pairs of frontoparietal nodes (2 and 7, 10 and 12),
and between executive, frontoparietal and sensorimotor nodes (see
Supplemental table S1.11.1 for summary of the credible edges). Among
these, there was weakened negative coupling when patients were un-
medicated compared to controls between DMN node 20 and executive
control node 5 (M: 0.03; HDI: 0.01–0.06; prop. > 0: 1.00). There was
also weaker positive coupling between the DAN (node 6) and sensor-
imotor node 17 (M: −0.03; HDI: −0.5 to −0.00; prop. < 0: 0.99),
and an absence of credible coupling between the DAN and visual node 8
(M: −0.04; HDI: −0.07 to −0.01; prop. < 0: 1.00) when comparing
controls to unmedicated patients. The negative correlation between the
auditory network (node 26) and the executive control network was
weakened by MPH (M: 0.02; HDI: −0.00–0.04; prop. < 0: 0.95).
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Please see Supplemental table S2.4 for summary of all posterior prob-
abilities for between group comparisons.
Several edges were correlated to overall task accuracy (see
Supplemental ﬁg. S1.11.1 for credible eﬀects and Supplemental table
S2.5 for summary of all regressions). Of particular interest were two
edges connected to the left VAN, as these two edges show a similar
pattern of connectivity when comparing controls to patients when on
placebo. A strong positive connection between DMN node 20 and left
VAN is associated with reduced task performance (M: −0.47; HDI:
−0.68 to −0.27; prop. < 0: 1.0), and this edge is more strongly
connected in unmedicated patients than controls (M: 0.03; HDI:
0.00–0.05; prop. < 0: 0.98). Additionally, increased accuracy was
associated with stronger positive coupling between frontoparietal nodes
10 and 12 (left VAN) (M: 0.41; HDI: 0.21–0.62; prop. > 0: 1.0), and
this edge was weaker for the unmedicated patients than for controls (M:
−0.03; HDI: −0.06 to −0.01; prop. < 0: 0.99).
3.6. Voxel-wise within-node connectivity
Of the eleven nodes that showed activity change in response to the
decision phase or other task parameters and showed group diﬀerences,
six had regions of signiﬁcant decrease or increase of within-node
connectivity when comparing groups (Supplemental ﬁg. S1.12.1 and
table S2.6). In the DMN node 1, and frontoparietal nodes 2 and 6 there
were patterns of both increased and decreased connectivity in controls
compared to placebo in all major divisions of the brain. Patients oﬀ
medication showed decreased connectivity along large parts of the
anterior cingulate cortex in the executive control node compared to
controls, and in subcortical node 29 and visual node 8 there were wide-
spread connectivity reductions in unmedicated patients were un-
medicated compared to the controls. The controls additionally had in-
creased connectivity in superior frontal regions of frontoparietal node
10 and 12 (left VAN) compared to unmedicated patients.
MPH changed within-node connectivity in three nodes. A large area
encompassing the precuneus showed strong attenuation in the MPH
condition compared to placebo in DMN node 1 (Fig. 3C), and there was
reduced connectivity in core visual regions of visual nodes 8 and 9.
4. Discussion
We tested the extent of large-scale brain network disruptions in
adult ADHD during a decision-making task, and their remediation by
MPH, using data-driven fMRI analyses in conjunction with Bayesian




















Fig. 3. Component time series signal variance and the DMN. Nodes showing credible diﬀerence between groups/conditions with regards to node variance. Triangles are the estimated
mean distributions for the groups, circles are the calculated diﬀerence distributions between groups (eﬀect of ADHD: controls- placebo; eﬀect of MPH: methylphenidate-placebo). (B) The
DMN temporal variance showed negative correlation to task accuracy, participants who performed well on the task also had little variance in the DMN, with no diﬀerence between the
groups. (C) The precuneus was more strongly connected to the rest of the DMN when patients were on placebo than on methylphenidate (C left: inﬂated brain). Mean connectivity scores
(error bars are 2 * standard deviation in both directions) from this ROI (p < 0.004) also indicate that the participants on placebo had higher connectivity than the controls, and that
patients on methylphenidate had closer to normal precuneus connectivity (C right: error bar plot). DMN= default mode network.
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and signal variance of 18 identiﬁed signal components (which we call
nodes), and the connectivity between these nodes (the edges), we found
aberrant activity and connectivity of the DMN in the ADHD sample.
Importantly, the nodes identiﬁed corresponded to common func-
tional resting-state networks, and all nodes but one displayed task-
dependent activity changes, suggesting the dynamics of intrinsic func-
tional networks were altered by cognitive engagement. Several analyses
indicated abnormal activation of the DMN in the patient sample. With
regards to the task-dependent activity changes in the functional net-
works, adults with ADHD showed increased levels of trial-by-trial
Fig. 4. Edge correlations. Top panel: Triangles are the estimated mean distributions for the groups, circles are the calculated diﬀerence distributions between groups. Error bars denote
the 95% highest density interval of the distribution. Bottom two rows depict the two nodes connected by the edge. Bottom panels: Graph representation of edges between nodes for
contrasts between patients when on placebo and controls (left), and edges correlated with overall task accuracy that are also diﬀerent between patients and controls (right). Blue lines
indicate a negative diﬀerence; red lines indicate a positive diﬀerence. The line thickness represents the magnitude of the diﬀerence. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the online version of this chapter.)
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suppression of the DMN compared to controls. Given the frequency of
choice trials and lack of rest-periods during scanning, increased DMN
suppression during each trial indicates that unmedicated patients were
less able to sustain DMN suppression while anticipating upcoming de-
cisions. This result was corroborated by increased DMN variance when
patients were oﬀ medication compared to controls, suggesting that
adults with ADHD displayed excessive DMN activity throughout the
task. Increased DMN variance was also correlated with reduced per-
formance on the task, which further supports the negative eﬀect of
excessive DMN activity during tasks. The DMN was additionally more
positively connected to the left ventral attention network (VAN), while
there was a general pattern of reduced connectivity between other
nodes in ADHD. Contrary to our expectations, there were few robust
eﬀects of MPH on network connectivity.
Multiple analytical approaches thus suggest that the DMN is over-
active in adults with ADHD during decision-making, as indicated by
increased trial-triggered DMN suppression and increased DMN signal
variance. A pattern of increased DMN signal variance, reduced coupling
between two attention nodes, and increased coupling between the DMN
and the left ventral attention network (VAN) was evident when patients
were unmedicated compared to controls, and also associated with re-
duced task performance across groups, indicating they are general
network changes correlated with reduced performance. MPH robustly
reduced precuneus connectivity in the DMN and reduced connectivity
within core visual nodes.
4.1. ADHD patients show reduced DMN down-regulation that is also
associated with reduced performance
The DMN was implicated in several analyses, both in regards to
quantifying diﬀerences between patients and controls, but also in re-
lation to task performance and eﬀects of MPH.
4.1.1. Variable DMN suppression during decision-making
The task GLMs indicate that DMN activity was reduced during the
decision phase in all participants and that reduced DMN activity was
also related to increased accuracy. This pattern was more pronounced
in patients than controls (Fig. 2). Given the diﬃculties with attention in
ADHD, and previous studies indicating that decreased DMN suppression
precedes attentional lapses (Weissman et al., 2006), it is possible that
patients struggle to keep DMN suppressed between trials, and need to
re-suppress it to execute the task. Such a process would result in the
greater trial-by-trial variation in DMN suppression seen in the patient
group.
The analyses of node signal variance corroborate this explanation,
as patients showed higher DMN variance than controls. Neural variance
is thought to partly reﬂect the ﬂexibility of the brain to explore and
adopt diﬀerent network conﬁgurations (Deco et al., 2011; Ghosh et al.,
2008), and, in this context, the DMN is expected to display decreased
variance during externally oriented tasks. Indeed, we found that in-
creased DMN signal variance was associated with poor task perfor-
mance (Fig. 3B). While a recent study found that increased DMN var-
iance in young adults was associated with increased performance on a
spatial working memory task (Guitart-Masip et al., 2015), the current
results indicate that DMN variability as measured by temporal variance
of a DMN independent component is associated with lower task per-
formance. Together these results provide novel evidence that adults
with ADHD show reduced sustained DMN suppression during decision-
making between trials and re-suppress the DMN at each choice, and
that such excessive DMN variance is associated with reduced task
performance.
The interpretation of the DMN as overactive in adult ADHD is in-
ferred by multiple analyses pointing in that direction. However, it was
not possible to test this possibility directly, as there were no longer
periods of rest during the experiment, nor did we have a resting con-
dition. We thus could not test the activation level of the DMN in non-
task periods. It is therefore also possible that increased task related
suppression and DMN variance result from greater dynamic range of the
DMN. However, given the current literature on the DMN in ADHD, and
that increased DMN variance was associated with reduced task per-
formance, this explanation seems unlikely.
4.1.2. Abnormal DMN connectivity with the precuneus and the left VAN
The two edges between the DMN nodes and frontoparietal node 12
were the only edges with higher positive correlations in unmedicated
patients than the controls Fig. 4. Frontoparietal node 12 includes the
temporoparietal junction, and inferior and middle frontal gyrus, and
likely reﬂects the left ventral attention network (VAN). The VAN is
commonly described as right lateralized, but these areas in the left
hemisphere have also been implicated as important to attention pro-
cesses (Vossel et al., 2014). Increased structural and functional con-
nectivity between attention networks and the DMN has been reported
previously in adult ADHD (Kessler et al., 2014), and reduced segrega-
tion between task-positive networks and the DMN has been suggested
to arise from reduced regulation of the DMN by task-positive networks
(Fassbender et al., 2009). These results are therefore consistent with
previous studies, and together suggest that the DMN is overly connected
to attention networks during cognitive engagement in ADHD, possibly
contributing to manifested symptoms of inattention.
Additionally, MPH decreased precuneus connectivity to the DMN in
the patient group (Fig. 3C). Precuneus activation has been implicated in
ADHD, where both higher activation during task engagement (Peterson
et al., 2009; Tomasi et al., 2009), and lower activation during rest
(Castellanos et al., 2008; Uddin et al., 2008) compared to controls were
reported. MPH has been found to increase DMN suppression in pre-
cuneus during a Stroop task in adolescents with ADHD (Peterson et al.,
2009). The precuneus has also been implicated in non-spatial atten-
tional shifts, and Tomasi et al. (2009) found that precuneus deactiva-
tion was ampliﬁed with increased cognitive load in a sustained atten-
tion task. These authors furthermore showed that MPH decreased levels
of DA transporter binding in the striatum (indicating increased DA in
the synapse), which in turn was related to increased precuneus deac-
tivation. MPH related precuneus connectivity may thus be mediated by
striatal inﬂuences. Alternatively, as DA transporter is, compared to NA
transporter, minimally expressed in the cortex (Schroeter et al., 2000),
precuneus connectivity may be altered by MPH through noradrenergic
inﬂuences.
More generally, while animal models of ADHD (Meneses et al.,
2011; Sagvolden et al., 1992) and most neurobiologically detailed
theories of ADHD propose a central role of DA (Ziegler et al., 2016), the
current evidence is consistent with the view that both DA and NA levels
are modulated by MPH, and their availability is associated with ADHD
symptoms. For instance, catecholamine transporter blockers of DA and
NA transporters aﬀect levels of both DA and NA (Han and Gu, 2006;
Bymaster et al., 2002; Seeman and Madras, 1998). Furthermore, a re-
cent functional connectivity study found MPH aﬀected connectivity of
cortical brain regions with the ventral tegmental area but also the locus
coeruleus (Kline et al., 2016).
Together with our results, this suggests that increased catechola-
mine signalling through MPH medication facilitates attention by mod-
ulating deactivation in precuneus, a key region of the DMN. These
observations are also in line with recent studies demonstrating de-
creased task-related DMN suppression in patients with schizophrenia
compared to controls (Haatveit et al., 2016) and in elderly compared to
young healthy adults (Garrett et al., 2015), in particular considering
that both schizophrenia and cognitive aging have been associated with
catecholamine alterations (Bäckman et al., 2010; Dørum et al., 2016;
Howes and Kapur, 2009).
4.1.3. Less segregated functional networks in ADHD
In addition to irregular connectivity in the DMN, there were pat-
terns of reduced within-network connectivity in visual, subcortical, and
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frontoparietal networks in patients oﬀ medication. Unmedicated pa-
tients furthermore exhibited decreased coupling between nodes within
the same network, like decreased coupling between two visual nodes
and two pairs of frontoparietal nodes Fig. 4, as well as increased cou-
pling between the DMN nodes and the left VAN. The combination of
widespread reduced connectivity within multiple nodes, decreased
coupling between nodes of the same network, and increased con-
nectivity between the DMN and VAN supports the hypothesis that pa-
tients with ADHD have more diﬀuse functional brain networks than
controls (Hoekzema et al., 2013). Indeed, using joint ICA combining
resting-state fMRI with MRI indices of white matter integrity and grey
matter morphology, Kessler et al. (2014) documented disruptions in
brain network diﬀerentiation in adult ADHD, with reduced within and
increased between network connectivity. It is possible that the more
diﬀuse network patterns in adult ADHD are the result of persistent
disruptions in brain network diﬀerentiation, and we here additionally
provide evidence that these disruptions might not be alleviated by acute
MPH medication.
4.2. Connectivity between nodes and task performance
While the strength of several edges displayed credible correlations
with overall task accuracy, of particular interest are two edges that in
addition were diﬀerent between patients and controls. Participants with
high task performance had a weak connection between the DMN and
the left VAN, and a strong connection between two task-positive net-
works (node 10 and VAN). Importantly, these eﬀects of connectivity
and task performance did not diﬀer between the groups. Unmedicated
patients had a stronger connection between the DMN and left VAN and
weaker connection between the two task-positive nodes than the con-
trols, and this is the same pattern associated with decreased task per-
formance across all participants. Interestingly, in task-positive node 10
and the VAN controls additionally have stronger frontoparietal with-
in–node connectivity than patients. It is thus not only that the con-
nection between the two task-positive networks is malfunctioning in
ADHD, but also that the nodes themselves are disrupted. These results
again support the hypothesis that brain networks are less diﬀerentiated
in ADHD and that network diﬀerentiation is connected to behaviour.
Another node of particular interest is frontoparietal node 6, which
likely reﬂects the dorsal attention network (DAN) and includes the in-
traparietal sulcus and insula; areas that have been linked to evidence
accumulation in perceptual and value-based decision making (Basten
et al., 2010; Furl and Averbeck, 2011). The DAN shows the largest
activation during the decision phase of all the nodes, and controls more
actively engaged the DAN than patients. Furthermore, the DAN was less
coupled to visual and sensorimotor nodes in patients oﬀ medication
compared to controls (Fig. 4). Studies have shown that the frontopar-
ietal network can dynamically change its degree of functional coupling
with perceptual and sensory areas based on task demands (Alnæs et al.,
2015; Chadick and Gazzaley, 2011), and that such changes in coupling
may act to bias perceptual decision processes (Wang et al., 2013). While
the edges connecting sensorimotor and visual nodes to the DAN were
not directly related to task performance, the diminished coupling be-
tween such regions in patients oﬀ medication may be a contributing
factor to reduced performance in the patient group.
4.3. Weak eﬀects of methylphenidate on functional connectivity
Other than the reduction in precuneus connectivity in the DMN
(Fig. 3C), the reduction of connectivity in two visual nodes, and de-
creased variance in the sensorimotor nodes, the drug manipulation
yielded fewer eﬀects than expected. Given the increase of DA avail-
ability brought about by MPH and DA's importance in reward signalling
(Volkow et al., 2009, 2001), we expected some eﬀects of medication on
brain networks. The primary, pre-registered analyses of this study were
concerned with the representation of task-speciﬁc information and the
integration of such information in the brain (Mowinckel et al., n.d.).
While the results supported several of our hypotheses, the eﬀects of
MPH were also weaker than anticipated. There we found that MPH
improved task accuracy, ameliorated the decreased representation of
gain magnitude in the left striatum, and that functional connectivity
between regions important for decision-making was improved by MPH
as a function of symptom severity. Possible explanations for the weak
eﬀects of MPH, such as sample size and characteristics, are discussed in
the limitations section.
With regard to network variance, MPH reduced network variance in
the sensorimotor network, but had no eﬀect on the DMN, which was the
only node where patients had aberrant variance. Given the previously
reported increase in BOLD variance in older participants as a result of d-
amphetamine (AMPH) (Garrett et al., 2015), which also improved task
performance, we expected similar eﬀects of MPH. Here we assessed the
temporal variance on dual-regression time-series, while Garrett et al.
(2015) calculated the standard deviation of all voxels across task
blocks, a diﬀerence which might explain result discrepancies. Also,
while AMPH and MPH both inhibit DA reuptake from the synapse,
AMPH additionally stimulates DA release (Fischer and Cho, 1979).
AMPH thus has two mechanisms by which DA availability increases,
likely resulting in higher availability of DA compared to MPH. Fur-
thermore, Garrett et al.'s (2015) older participants had decreased BOLD
variability in regions important to task execution, which was improved
by AMPH. The only network with aberrant variance in patients in the
current study was the task-negative DMN, and MPH did not alleviate
this abnormality. In contrast, the eﬀects of MPH on network variability
in the current sample were reductions of variance in the sensorimotor
network and the OFC. It is possible to interpret this reduction as an
attenuation of overactive motor processes in ADHD (Mostofsky et al.,
2006), but as none of these nodes exhibited abnormal variance, this
seems unlikely.
While we observed within-network changes in response to MPH in
the precuneus of the DMN and in core visual areas of visual networks,
these changes are network speciﬁc. MPH might more successfully in-
crease within-network connectivity, while not being strong enough to
alleviate developmental disruptions in larger between-network dy-
namics. Although speculative, increasing connectivity within networks
that are already established, but function at a reduced capacity, might
be easier than changing disruptions between diﬀerent networks that
themselves function sub-optimally.
5. Limitations
In order to study deﬁcits in adults with ADHD, without the un-
certainty that follows from a patient sample with multiple comorbid-
ities that require treatment with other psychopharmacological sub-
stances, our patient sample might not be generalizable to the whole
ADHD population. While we deliberately matched patients and controls
on key characteristics such as gender and age, we were more lenient
when it came to educational attainment. The choice of leniency arose
from the proposal that “overmatching” on certain characteristics that
have arisen as a result of the disorder itself would lead to an under-
estimation of the abnormalities associated with the disorder (Seidman
et al., 1997). Such multi-collinearity is often dealt with by statistically
controlling for other regressors, but leads to uninterpretable results as
naturally co-occurring phenomena are artiﬁcially separated (Miller and
Chapman, 2001).
Another limitation arises from our wish to test the eﬀects of MPH on
a sample of adults who were receiving treatment with MPH; all patients
had therefore been receiving MPH treatment for a minimum of one
month prior to testing. Previous studies of MPH eﬀects in healthy adults
have been on MPH-naïve participants, and the PET literature suggests
strong eﬀects of acute MPH on DA transporter binding in the striatum in
previously unmedicated adults with ADHD (Tomasi et al., 2009;
Volkow et al., 2007). Studies on the eﬀects of MPH in patients used
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patients having received long-term medication (Liddle et al., 2011).
Using ADHD patients on MPH treatment has two related implications
for the interpretation of our results. First, it is possible that the diﬀer-
ence between the on and oﬀ MPH conditions is due to withdrawal ef-
fects, as opposed positive eﬀects of MPH in the MPH condition. Second,
because it is known that MPH can also have chronic eﬀects on neuro-
transmitter functioning, it is possible that our results underestimate the
full eﬀects of MPH, because acute cession of MPH will not remove the
chronic eﬀects. A generalization of our results to a population of pa-
tients who have never received MPH should therefore be made cau-
tiously. We outline elsewhere the experiments required to diﬀerentiate
acute and chronic eﬀects of MPH (Ziegler et al., 2016). The very low to
unidentiﬁable levels of ritalinic acid in the blood of the patients in the
placebo condition at least make it unlikely that patients were under the
inﬂuence of MPH in the placebo condition.
Finally, due to an MRI scanner upgrade data-collection ended pre-
maturely, resulting in a smaller ADHD sample than aimed for. While the
sample size is comparable to that of other fMRI studies in ADHD
(Cortese et al., 2012), it might still not be enough to robustly detect
changes in network dynamics as studied here. However, the use of
rigorous statistical methods through permutation testing and Bayesian
inference should ensure the robustness of the results reported here,
despite some of its limitations.
6. Conclusions
This study provided novel evidence for diﬃculties in sustaining
DMN suppression during decision-making in adults with ADHD, which
necessitates re-suppression of the DMN at each choice. The excessive
activation of the DMN was also associated with poor task performance
and corroborated by two diﬀerent analytical approaches. While we
found no evidence of a positive eﬀect of MPH on the stability of DMN
suppression, MPH decreased precuneus connectivity in the DMN, which
is commonly found in studies of DA agonists. Moreover, a pattern of
higher connectivity between and lower connectivity within the left
ventral attention network and the DMN was not only associated with
reduced task performance, but also found in the patient sample com-
pared to controls. The results of this study thus support the default
mode interference hypothesis, in that excessive activity of the DMN is
both evident in adults with ADHD and associated with lower task
performance. We also provided further support towards reduced brain
network diﬀerentiation in ADHD, which here was not remediated by
MPH medication.
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